SMARCD1 and breast cancer: Given that positive and negative modulation of Smarcd1 expression in mouse mammary cancer cell lines resulted in increased tumorsphere formation and alternative splicing of a common clinically relevant gene set, we next sought to determine if changes in Smarcd1 expression modify metastasis in vivo.